Auteurs

Matthew Royle, Ph.D.

Associé

Read More

Judith Krens

Associé

Read More

Dr. Manja Epping

Associé

Read More

Evelyne Friedel

Associé

Read More
Auteurs

Matthew Royle, Ph.D.

Associé

Read More

Judith Krens

Associé

Read More

Dr. Manja Epping

Associé

Read More

Evelyne Friedel

Associé

Read More

22 septembre 2019 |

Biosimilars - clearing the way for launch

Many of the top-selling drugs worldwide are biologics, and several companies are seeking to produce biosimilars to compete in these lucrative markets. There are an increasing number of biologics reaching the end of the primary patent protection and these companies must navigate the landscape of secondary patent protection in order to launch their biosimilars. The strategies for doing so differ in the US and Europe and there are different tools available.

In this third session we focus on strategic options for securing an early launch of a biosimilar. In particular:

  • devising a strategy to clear the way in Europe
  • do-called Arrow declarations may be available to provide a defence to any pending patent applications
    • in the Netherlands, a recent case has clarified the court's jurisdiction to consider Arrow relief
    • in the UK, a recent case has clarified the circumstances in which an Arrow declaration will be granted
  • devising a strategy to clear the way in the US.

View session 1

View session 2


Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

centrifuge-machine
Sciences de la vie et Santé

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

27 juillet 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus
woman-with-scientific-model
Sciences de la vie et Santé

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 avril 2020

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Termination, force majeure and frustration – international perspectives on the life sciences sector

17 avril 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus

Événements connexes